CDH1 and lip and oral cavity carcinoma: A meta-analysis based on 13 studies revealed that increased methylation of the promoter of CDH1 is associated with oral cancer risk (Wen et al. 2018), and it has been suggested that this hypermethylation is associated with lower expression of E-cadherin protein in OSCC patients (Pannone et al. 2014).